Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.

por Adélaide, J., Monges, G., Dérdérian, C., Seitz, J. F., Birnbaum, D.
Publicado 1995

Multicolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines

por Letessier, A, Mozziconacci, M-J, Murati, A, Juriens, J, Adélaïde, J, Birnbaum, D, Chaffanet, M
Publicado 2005

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.

por Jacquemier, J., Molès, J. P., Penault-Llorca, F., Adélaide, J., Torrente, M., Viens, P., Birnbaum, D., Theillet, C.
Publicado 1994

A seven-gene prognostic model for platinum-treated ovarian carcinomas

por Sabatier, R, Finetti, P, Bonensea, J, Jacquemier, J, Adelaide, J, Lambaudie, E, Viens, P, Birnbaum, D, Bertucci, F
Publicado 2011

Molecular characterization of breast cell lines: a tool for breast cancer studies

por Charafe-Jauffret, E, Ginestier, C, Monville, F, Adélaïde, J, Finetti, P, Bertucci, F, Xerri, L, Jacquemier, J, Birnbaum, D
Publicado 2005

Integrated Genomic Analysis of Breast Cancers

por Addou-Klouche, L, Adélaïde, J, Cornen, S, Bekhouche, I, Finetti, P, Guille, A, Sircoulomb, F, Raynaud, S, Bertucci, F, Birnbaum, D, Chaffanet, M
Publicado 2012

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes

por Brecqueville, M, Cervera, N, Gelsi-Boyer, V, Murati, A, Adélaïde, J, Chaffanet, M, Rey, J, Vey, N, Mozziconacci, M J, Birnbaum, D
Publicado 2011

Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification

por Cervera, N, Carbuccia, N, Mozziconacci, M-J, Adélaïde, J, Garnier, S, Guille, A, Murati, A, Chaffanet, M, Vey, N, Birnbaum, D, Gelsi-Boyer, V
Publicado 2017

Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms

por Brecqueville, M, Cervera, N, Adélaïde, J, Rey, J, Carbuccia, N, Chaffanet, M, Mozziconacci, M J, Vey, N, Birnbaum, D, Gelsi-Boyer, V, Murati, A
Publicado 2011

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia

por Collette, Y, Prébet, T, Goubard, A, Adélaïde, J, Castellano, R, Carbuccia, N, Garnier, S, Guille, A, Arnoulet, C, Charbonier, A, Mozziconacci, M J, Birnbaum, D, Chaffanet, M, Vey, N
Publicado 2015

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study

por Collignon, A., Hospital, M. A., Montersino, C., Courtier, F., Charbonnier, A., Saillard, C., D’Incan, E., Mohty, B., Guille, A., Adelaïde, J., Carbuccia, N., Garnier, S., Mozziconacci, M. J., Zemmour, C., Pakradouni, J., Restouin, A., Castellano, R., Chaffanet, M., Birnbaum, D., Collette, Y., Vey, N.
Publicado 2020